Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

This study has been completed.
Information provided by:
Fred Hutchinson Cancer Research Center Identifier:
First received: November 2, 2007
Last updated: April 21, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)